Àü¸³¼±ºñ´ëÁõ ȯÀÚ¿¡¼ 5¾ËÆÄȯ¿øÈ¿¼Ò ¾ïÁ¦Á¦ Åõ¿©°¡ Survivin°ú Bcl-2ÀÇ ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ
Expression of Survivin and Bcl-2 in Benign Prostatic Hyperplasia Treated with a 5-alpha-reductase Inhibitor
Â÷¿ìÇå, Àå¼®¿ë, ÀÌ°æ¼·,
¼Ò¼Ó »ó¼¼Á¤º¸
Â÷¿ìÇå ( Cha Woo-Heon )
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Àå¼®¿ë ( Jang Suk-Yong )
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌ°æ¼· ( Lee Kyung-Seop )
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358320080490030242
Abstract
Purpose: A 5-alpha-reductase inhibitor(5?RI) can induce apoptosis and decrease the prostatic volume in patients with benign prostatic hyperplasia (BPH). In this study we assessed the expression of survivin and bcl-2 in the epithelium of BPH patients treated with finasteride.
Materials and Methods: Group 1 consisted of 39 patients who underwent transurethral resection of the prostate(TURP) without medication and Group 2 consisted of 31 patients who underwent TURP and were treated with finasteride for more than three months. The mean age of both groups of patients was 73.03¡¾7.02 years and 74.71¡¾5.99 years, respectively. Immunohistochemical staining for survivin, bcl-2 and ki-67 was performed in prostatic tissues. The percentage of cells that expressed survivin and bcl-2 were classified into four categories based on the staining intensity. The expression of ki-67 in nuclei using 10 random cells per specimen was obtained. The relationship between 5?RI and the expression of survivin, bcl-2 and ki-67 was analyzed.
Results: The total mean prostate volume of group 1 patients and group 2 patients was 45.51ml and 37.23ml, respectively (p£¼0.001) and the mean serum total prostate specific antigen(PSA) level of group 1 patients and group 2 patients was 5.09ng/ml and 3.75ng/ml, respectively(p=0.105). Decreased expression of survivin and bcl-2 in specimens from group 2 patients was observed as compared to the level of expression in group 1 patients(p£¼0.001, p=0.001). Expression of ki-67 determined in samples from both groups was not significantly different(p=0.345).
Conclusions: We suggest that finasteride may induce apoptosis of prostatic epithelial cells in BPH patients by reducing the expression of survivin and bcl-2. These findings may indicate a reduction of prostatic volume. (Korean J Urol 2008;49:242-247)
Å°¿öµå
Prostatic hyperplasia;Apoptosis;Survivin;Bcl-2
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸